You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
奧泰生物(688606.SH):2024年度淨利潤3.04億元 同比增長68.18%
格隆匯 02-26 16:04

格隆匯2月26日丨奧泰生物(688606.SH)公佈2024年度業績快報,報告期內,公司實現營業總收入8.7億元,較上年同期增長15.25%;實現歸屬於母公司股東的淨利潤3.04億元,較上年同期增長68.18%;實現歸屬於母公司所有者的扣除非經常性損益的淨利潤2.39億元,較上年同期增長62.92%。

影響經營業績的主要原因:(1)公司持續深耕體外診斷行業的POCT細分領域,始終堅持研發創新策略,通過持續的高研發投入,確保每月都有新產品上市,從而不斷強化並鞏固公司在POCT行業的創新領先地位;(2)公司精準把握市場動態,深入挖掘客戶需求,深化市場開拓策略,積極發揮在研發、質量、服務等多方面的核心競爭力優勢,進一步提升產品競爭力以及客戶銷售額;(3)公司在“控本、增效、提質”方面不斷挖掘潛力,強化內部精細化管理,生產自動化以及規模化效應日益顯著。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account